Travis Rump, DO
Orthopaedic Surgery · Salina, KSNPI 1699181339
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.5%), education and speaking fees — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Arthrex at 44.4% of the total. Reporting peaked in 2019 at $12,585 and has fallen 97.5% since, to $316 in 2025.
Across 157 payments — averaging $239.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$17K
- Stryker$12K
- Titan Surgical Group, LLC$5K
- Smith+Nephew$1K
- Si-bone, Inc.$1K
- Johnson & Johnson$671
- plus $321 from 7 others
What the payments were for
- Speaking & faculty fees$7,00019%
- Travel & lodging$14,44538%
- Food & beverage$5,79815%
- Education$10,21427%
- Gifts$940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 52 | $16,661 |
| Stryker(2 entities) | 50 | $11,671 |
| Titan Surgical Group, LLC | 15 | $5,475 |
| Smith+Nephew | 16 | $1,394 |
| Si-bone, Inc. | 7 | $1,358 |
| Johnson & Johnson | 9 | $671 |
| Zimmer Biomet | 2 | $179 |
| Linvatec Corporation | 1 | $42 |
| Innovation Technologies Inc | 1 | $38 |
| Vericel Corporation | 1 | $21 |
| Heron Therapeutics, Inc. | 1 | $17 |
| Pfizer | 1 | $12 |
| Medtronic | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NONE$4,418
- MAKO$2,531
- TRIATHLON$1,481
- TRIDENT$1,344
- ACCOLADE$1,344
- IFUSE IMPLANT SYSTEM$1,050
- CORI$903
- Ascend Flex$644
- PELVIS II$147
- RESTORATION$132
- REAL INTELLIGENCE$123
- TFN-Advance$121
- HAMMERLOCK$121
- AEQUALIS PERFORM REVERSED$100
How this compares
$37,550 in reported general payments places this provider in the 85th percentile of 197 orthopaedic surgery providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 14 | $308 |
| Oxycodone Hcl | 51 | $177 |
| Cephalexin | 30 | $173 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $117 |
| Ondansetron Hcl | 41 | $99 |
| Ondansetron OdtOndansetron | 14 | $60 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 61 | $58 |
| Clindamycin Hcl | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Salina
- David AndersonKansas City$490K
- Brandon CarlsonKansas City$299K
- Jacob DeisterTopeka$185K
- Harold EllsworthLeawood$154K
- Tyler BronWichita$107K
- William ReedLenexa$106K
- Alexander BaileyOverland Park$99K
- Brent WiseKansas City$97K
- Joshua LockerLeawood$91K
- Jeffrey ShepherdWichita$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.